Corrigendum to 'Effects of RG7652, a Monoclonal Antibody Against PCSK9, on Low-Density Lipoprotein Cholesterol (LDL-C), LDL-C Subfractions, and Inflammatory Biomarkers in Patients at High Risk of or with Established Coronary Heart Disease (From the Phase 2 EQUATOR Study)' The American Journal of Cardiology 119 (2017) 1576-1583.
Am J Cardiol
; 122(3): 527, 2018 Aug 01.
Article
de En
| MEDLINE
| ID: mdl-29448977
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Type d'étude:
Etiology_studies
/
Risk_factors_studies
Langue:
En
Journal:
Am J Cardiol
Année:
2018
Type de document:
Article